Mohamed El-Wakil

Dr. Mohamed El-Wakil


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2010 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
HEHadir A. El‐Mahallawy
Hadir A. El‐Mahallawy
MEMohamed El-Wakil
Mohamed El-Wakil
MMManar M. Moneer
Manar M. Moneer
LSLobna Shalaby
Lobna Shalaby

6 March 2017 in Virology Journal
Verified
Journal Article
Open access
PDF file
SLsamah loutfy
samah loutfy
MAMaha A. Abo-Shadi
Maha A. Abo-Shadi
MFMohamed Fawzy
Mohamed Fawzy
MEMohamed El-Wakil
Mohamed El-Wakil
SMShimaa A. Metwally
Shimaa A. Metwally
AEAhmed Elgebaly
Ahmed Elgebaly
Epstein-Barr virus (EBV) and human cytomegalovirus (CMV) infections are environmental risk factors affecting the outcome of cancer due to an impairment in the cell-mediated immunity. Therefore, this study aimed to detect the frequency of EBV and CMV DNA and their association with clinical characteristics and outcome of pediatric leukemic patients. Samples of 50 immunocompromised pediatric leukemic patients and 30 apparently healthy children were subjected to the amplification of EBV DNA by one version of PCR targeting the Bam H1 W region of the genomic region of EBV, and the amplification of CMV DNA by targeting the CMV UL97 genomic region by a second round PCR. All investigations were performed on WBCs and sera. Results were correlated with the clinical and laboratory characteristics of the disease, and with overall survival. EBV and CMV DNA were detected in 20 and 54% of leukemic patients, respectively. Nine out of ten patients with EBV DNA (90%) were positive for CMV DNA in their sera. The presence of EBV DNA or CMV DNA was associated with neutropenia and a low total leukocyte count (TLC) (p = 0.02, 0.03, respectively). The presence of severe CMV disease, longer duration of febrile neutropenia, neutropenia, lymphopenia, thrombocytopenia and the presence of EBV DNA in patients’ sera were significantly associated with worse overall survival. The detection of CMV disease and EBV DNA is relatively common in leukemic children and is significantly associated with a decline in the overall survival.